(Q42997364)

12 November 2017

title

Targeted therapies: Pazopanib: carving a niche in a crowded therapeutic landscape (English)

1 reference

12 November 2017

Sumanta Kumar Pal

1

1 reference

12 November 2017

Robert A Figlin

series ordinal

2

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Nature Reviews Clinical Oncology

12 November 2017

published in

1 reference

12 November 2017

volume

7

1 reference

12 November 2017

issue

7

1 reference

12 November 2017

page(s)

362-363

1 reference

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.83

Crossref

reference URL

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.83

Crossref

reference URL

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.83

Crossref

reference URL

10.1038/NRCLINONC.2010.83

31 March 2020

Identifiers

DOI

1 reference

12 November 2017

1 reference